Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia

Journal of Lipid Research

Volumn 32, Issue 6, 1991, Pages 935-940

  Elmberger, P G ^a   Kalen, A ^a   Lund, E ^a   Reihner, E ^a   Eriksson, M ^a   Berglund, L ^a   Angelin, B ^a   Dallner, G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cholesterol; dolichol; lathosterol; lipoproteins; liver biopsy; ubiquinone

Indexed keywords

COLESTYRAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVALONIC ACID; PRAVASTATIN; UBIQUINONE;

ARTICLE; CLINICAL ARTICLE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; LIVER BIOPSY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; CHOLESTEROL; CHOLESTYRAMINE; DOLICHOL; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA, FAMILIAL; MALE; MEVALONIC ACID; MIDDLE AGE; PRAVASTATIN; SUPPORT, NON-U.S. GOV'T; UBIQUINONE;

EID: 0025728462     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)